What companies are VRTX's competitors?

Vertex Pharmaceuticals Incorporated (VRTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does VRTX compare to its peers?

The peer comparison table on this page shows Vertex Pharmaceuticals Incorporated (VRTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does VRTX operate in?

Vertex Pharmaceuticals Incorporated (VRTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

VRTX

Vertex Pharmaceuticals Incorporated

NASDAQ·Biotechnology · Healthcare

$528.90$17.22−3.15%

After hours·$527.54−0.26%

Market cap$134.24B·Market closed·Sep 8 8:00 PM UTC

Frequently Asked Questions About VRTX

What companies are VRTX's competitors?: Vertex Pharmaceuticals Incorporated (VRTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does VRTX compare to its peers?: The peer comparison table on this page shows Vertex Pharmaceuticals Incorporated (VRTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does VRTX operate in?: Vertex Pharmaceuticals Incorporated (VRTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

VRTX

Vertex Pharmaceuticals Incorporated

NASDAQ·Biotechnology · Healthcare

$528.90$17.22−3.15%

After hours·$527.54−0.26%

Market cap$134.24B·Market closed·Sep 8 8:00 PM UTC

Peers


BMY	Bristol-Myers Squibb Company	$64.69	$132.1B
CVS	CVS Health Corp.	$96.07	$122.6B
MDT	Medtronic plc	$92.39	$118.3B
SYK	Stryker Corporation	$276.43	$106.0B
MCK	McKesson Corporation	$889.12	$104.1B
SNY	Sanofi	$43.16	$103.6B
GSK	GSK plc	$48.54	$97.2B
HCA	HCA Healthcare, Inc.	$402.02	$87.0B
REGN	Regeneron Pharmaceuticals, Inc.	$810.31	$83.5B
ARGX	argenx SE	$1,007.07	$62.6B

Frequently Asked Questions About VRTX

What companies are VRTX's competitors?: Vertex Pharmaceuticals Incorporated (VRTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does VRTX compare to its peers?: The peer comparison table on this page shows Vertex Pharmaceuticals Incorporated (VRTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does VRTX operate in?: Vertex Pharmaceuticals Incorporated (VRTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.